Curated News
By: NewsRamp Editorial Staff
March 12, 2026
Nephros Reports Record 33% Revenue Growth, Second Year of Profitability
TLDR
- Nephros achieved record revenue growth of 33% to $18.8 million and positive net income for the second consecutive year, strengthening its market position.
- Nephros' growth strategy focuses on three pillars: product portfolio expansion, in-house service capabilities, and the new Nephros Water Institute for education.
- Nephros' water filtration technology and educational initiatives improve water safety and public health through pathogen mitigation in healthcare and commercial settings.
- Nephros maintained a 62% gross margin despite tariff challenges and operates debt-free with $5.4 million in cash, showing financial resilience.
Impact - Why it Matters
This news matters because Nephros' strong financial performance demonstrates the growing importance of water safety technology in healthcare and commercial markets. As concerns about waterborne pathogens and facility water safety continue to rise globally, companies providing effective filtration solutions are positioned for sustained growth. Nephros' success in expanding beyond traditional healthcare applications into broader commercial markets indicates increasing awareness and regulatory focus on water quality across industries. The company's integrated approach combining products, services, and education creates a comprehensive solution that addresses both proactive and emergency water management needs. For investors, Nephros represents a growing player in the essential water technology sector with demonstrated revenue growth and improving profitability. For healthcare facilities, commercial buildings, and other institutions, Nephros' solutions offer critical protection against waterborne contaminants that can cause serious health issues and operational disruptions. The company's expansion of service capabilities and educational initiatives through the Nephros Water Institute further strengthens its position as a leader in this vital field.
Summary
Nephros, Inc., a leading water technology company specializing in filtration solutions for medical and commercial markets, has announced impressive financial results for the fourth quarter and fiscal year ended December 31, 2025. The company reported a 33% year-over-year increase in full-year net revenue to $18.8 million, with fourth-quarter revenue up 22% to $4.7 million. This marks Nephros' second consecutive year of positive net income, achieving $1.2 million for 2025 compared to just $74,000 in 2024. President and CEO Robert Banks described 2025 as "transformational" for the company, attributing success to a disciplined strategy built around three growth pillars: Products, Service, and Education. The company's differentiated product portfolio, expansion of reorder rates, deployment of additional sales associates, and growth beyond traditional healthcare applications all contributed to these strong results.
Key players in Nephros' success include Alfred Vargas, Director of Service, who led the expansion of installation and replacement capabilities, and Brianne McGuire, Director of Business Development, who spearheaded the launch of the Nephros Water Institute. The company also extended its long-term supply agreement with key partner Medica, ensuring continuity of supply. Despite facing challenges from U.S. tariffs on goods imported from Italy, which impacted margins in the second half of 2025, Nephros maintained a strong financial position with $5.4 million in cash and cash equivalents as of December 31, 2025, and remains debt-free. The company's adjusted EBITDA for the year reached $1.6 million, a significant increase from $548,000 in 2024, demonstrating improved operational efficiency.
Looking forward, Nephros continues to position itself as an authority in waterborne pathogen mitigation and facility water safety through its integrated approach. The company's service offering expansion has reduced barriers to adoption and strengthened customer relationships, while the Nephros Water Institute expands engagement with customers and industry stakeholders. Investors can access more information through the Nephros Investor Relations page, and the company will host a conference call to discuss these results further. This announcement was distributed through PRISM MediaWire, a trusted press release distribution service, highlighting the company's commitment to transparency and investor communication.
Source Statement
This curated news summary relied on content disributed by PRISM Mediawire. Read the original source here, Nephros Reports Record 33% Revenue Growth, Second Year of Profitability
